Parison Amy, SVP and Chief Financial Officer of Editas Medicine ($EDIT), made five open market sales of company shares over the last year, totaling $5,660. Her most recent sale occurred on March 3, 2026. These transactions rank 11,389th out of 11,678 insiders in our database, well below the average sale amount of $8.6 million and 6.37 transactions per insider. Parison Amy recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | A | Stock Option (right to buy) | 292856 | $0.00 | 292,856.0000 | 97,618,660 | 9999.99% | 0.30% |
| March 3, 2026 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 474 | $2.02 | 15,434.0000 | 97,618,660 | 2.98% | 0.00% |
| Dec. 3, 2025 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 461 | $2.15 | 15,908.0000 | 97,618,660 | 2.82% | 0.00% |
| Sept. 3, 2025 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 458 | $2.60 | 16,369.0000 | 82,976,284 | 2.72% | 0.00% |
| Aug. 7, 2025 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 679 | $2.58 | 16,827.0000 | 82,976,284 | 3.88% | 0.00% |
| June 3, 2025 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | S | Common Stock | 446 | $1.72 | 17,506.0000 | 82,976,284 | 2.48% | 0.00% |
| April 8, 2025 | Editas Medicine, Inc. | $EDIT | Parison Amy | SVP, Chief Financial Officer | A | Stock Option (right to buy) | 34672 | $0.00 | 34,672.0000 | 82,976,284 | 9999.99% | 0.04% |